David Nutt

✓ Source-basedstable

British psychiatrist, neuropsychopharmacologist

United Kingdom WritersBorn 1951 · age 75

CompareClaim

Fame51.1

Momentum3.5

Languages11

In century#41,586

Text from Wikipedia, CC BY-SA 4.0

Also inDeutsch

Photos 2

Simplified visualization of the persistence homological brain function scaffolds from placebo on the left and that induced through psilocybin on the right[36]

Awards 2

2013John Maddox Prize

2002Fellow of the Academy of Medical Sciences

Connected to David 6

Elisabeth BikAlso won John Maddox Prize

Eleanor A. MaguireAlso won Fellow of the Academy of Medical Sciences

Edzard ErnstAlso won John Maddox Prize

Elizabeth LoftusAlso won John Maddox Prize

Sarah GilbertAlso won Fellow of the Academy of Medical Sciences

Onora O'NeillAlso won Fellow of the Academy of Medical Sciences

About this person

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. In 2019 he co-founded the company GABAlabs and its subsidiary SENTIA Spirits which research and market alternatives to alcohol. Until 2009, he was a professor at the University of Bristol heading their Psychopharmacology Unit. Since then he has been the Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there. Nutt was a member of the Committee on Safety of Medicines, and was President of the European College of Neuropsychopharmacology.

Text from Wikipedia, CC BY-SA 4.0

Country

United Kingdom